SOURCE: Cypress Bioscience, Inc.

May 01, 2008 06:30 ET

Cypress Bioscience, Inc. to Present at Deutsche Bank Health Care Conference

SAN DIEGO, CA--(Marketwire - May 1, 2008) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Michael R. Hufford, PhD, its Vice President of Corporate Development, will present at Deutsche Bank's 33rd Annual Health Care Conference on Tuesday, May 6, 2008.

The Deutsche Bank conference is being held at the InterContinental Boston Hotel, Boston, MA. Dr. Hufford is scheduled to present on Tuesday, May 6th at 4:10 p.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=CYPB&item_id=1827495.

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/news/events.php.

About Cypress Bioscience, Inc.

Cypress Bioscience is committed to developing and commercializing pharmaceutical products and personalized medicine laboratory services that allow physicians to serve unmet medical needs. Cypress' strategy involves evaluating various other potential strategic transactions, including the potential acquisition of products, product candidates, technologies and companies, and other alternatives.

For more information about Cypress, please visit the Company's website at www.cypressbio.com.

Contact Information

  • For additional information please contact
    For Cypress Bioscience:
    Michael Hufford
    VP Corporate Development
    Mary Gieson
    Investor Relations
    (858) 452-2323
    Email Contact